financetom
Business
financetom
/
Business
/
Coca-Cola posts surprise revenue jump on higher prices, steady demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coca-Cola posts surprise revenue jump on higher prices, steady demand
Feb 11, 2025 5:05 AM

(Reuters) -Coca-Cola posted a surprise rise in comparable revenue and topped estimates for fourth-quarter profit on Tuesday, helped by higher prices and resilient demand for its sodas, sending the company's shares up about 4% premarket.

The company has focused on capturing demand in emerging markets such as India and expanding its portfolio in North America to include brands such as the premium Fairlife milk label, as well as the sparkling water brand Topo Chico.

Partnerships with value meal deals at fast-food chains such as McDonald's have also buoyed sales.

Quarterly volumes rose across Coca-Cola's global markets for the first time in 2024, with North America posting a 1% growth in the fourth quarter.

At the same time, global prices rose 9% in last three months of 2024, following a 10% jump in the third quarter.

Coca-Cola has benefited from robust demand for its sparkling soft drink brands such as Fanta and Sprite, with volumes rising 2% in the segment. It accounts for about two-thirds of the company's total volumes.

In contrast, rival PepsiCo ( PEP ) last week reported a 3% drop in volume for its two biggest segments of North America beverages and Frito-Lay North America for the fourth quarter.

"That's probably key difference versus Pepsi. Pepsi has been losing share in North America in sparkling beverages and Coca-Cola has been outperforming in no-sugar and sparkling in particular," said Charlie Higgs, director of Consumer Staples Research at Redburn Atlantic.

Coca-Cola's fourth-quarter comparable net revenue rose 4.2% to $11.40 billion, while analysts had expected it to drop 2.47% to $10.68 billion, according to data by LSEG.

The company's profit of 55 cents per share topped estimates of 52 cents.

Coca-Cola expects organic revenue growth of 5% to 6% for 2025, compared with a 12% rise in 2024. The forecast is at the higher end of the company's long-term organic revenue growth target of between 4% and 6%.

(Reporting by Juveria Tabassum in Bengaluru; Editing by Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alkami Technology, Greenlight Financial Collaborate on Youth Banking
Alkami Technology, Greenlight Financial Collaborate on Youth Banking
Mar 26, 2025
12:39 PM EDT, 03/26/2025 (MT Newswires) -- Alkami Technology ( ALKT ) said Wednesday it is collaborating with Greenlight Financial Technology to provide kids and teens with money management tools and financial education. The partnership allows Alkami's ( ALKT ) clients to offer their account holders access to Greenlight, whose family finance app enables the youth to earn, save, spend...
Italian wine exports to US 'at standstill' due to tariff fears
Italian wine exports to US 'at standstill' due to tariff fears
Mar 26, 2025
MILAN (Reuters) -Italian wine and spirits exports to the United States are stalling due to the uncertainty over possible tariffs that President Donald Trump could impose in the coming weeks, trade group Federvini said on Wednesday. Trump has threatened to slap a 200% tariff on wine and other alcohol imports from Europe, as part of a developing trade war also...
Microsoft pulls back from more data center leases in US and Europe, analysts say
Microsoft pulls back from more data center leases in US and Europe, analysts say
Mar 26, 2025
March 26 (Reuters) - Microsoft ( MSFT ) has abandoned data center projects set to use 2 gigawatts of electricity in the U.S. and Europe in the last six months due to an oversupply relative to its current demand forecast, TD Cowen analysts said on Wednesday. The tech giant's backtracking includes deferrals and cancellations of existing data center leases in...
Johnson & Johnson Reports Positive Data from Phase 3 Study of Lung Cancer Drug Candidate
Johnson & Johnson Reports Positive Data from Phase 3 Study of Lung Cancer Drug Candidate
Mar 26, 2025
12:37 PM EDT, 03/26/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday that results from a phase 3 trial showed that Rybrevant as a conjugate therapy significantly extended overall survival in certain cancer patients. The drug was studied in combination Lazcluze as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer, NSCLC, compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved